MRI-guided treatment to preserve the rectum in rectal cancer
Part of Cancer, Digestive system clinical trials.
This study tests a new MRI-guided approach to treat rectal cancer without removing the rectum, aiming to preserve quality of life. It may be an option for patients with stage II or III rectal cancer who are healthy enough for intensive treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have stage II or stage III rectal cancer that has not spread to distant organs.
- You have not had radiation therapy to the pelvic area before.
- You are generally in good health (ECOG score 0-2) and can tolerate intensive treatment.
- Your blood test results meet certain minimum levels (e.g., white blood cells, platelets, hemoglobin, liver function).
- You are able to undergo an MRI scan (no metal implants or claustrophobia that prevent it).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies a total “before-surgery” treatment plan for locally advanced rectal cancer, using MRI (a detailed scan) to help guide radiation. It may help patients by aiming to shrink the tumor and improve the chance of successful surgery.
This trial tests a new type of radiation therapy that uses real-time MRI imaging to adjust the radiation precisely to your tumor. It is designed to improve the accuracy of treatment for locally advanced rectal cancer, potentially reducing damage to nearby healthy tissue.
This trial tests a new way to give high-dose radiation to rectal cancer tumors while avoiding the bladder and bowels. The goal is to cure the cancer without removing the rectum, so you may keep normal bowel function.
This trial tests whether combining chemotherapy with high-dose radiation guided by MRI (a special scan) can better treat low rectal cancer. It may help shrink the tumor and improve local control while targeting the tumor more precisely.
This study looks at how an MRI “score” (mrTRG) matches how well locally advanced rectal cancer shrinks after pre-surgery chemotherapy and radiation. The goal is to use MRI results to better predict treatment response and guide care.
This study uses PET/MRI scans to look at rectal cancer in detail. It may help doctors plan treatment more accurately. The study is for people with stage 2-3 rectal cancer who will get chemotherapy and radiation before surgery.
Hear when a new Rectal Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.